Chikungunya Virus Infection
📧 Sign up to get email alerts when something new happens for Chikungunya Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-31Clinical Trial Update: A Trial to Evaluate the Safety and Immunogenicity of VLA1553 in Healthy Children [Phase 3]
A Phase 3 trial evaluating Valneva’s chikungunya vaccine VLA1553 in healthy children has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-02Clinical Trial Update: A Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV) [Phase 3]
A Phase 3 trial of Valneva's chikungunya vaccine VLA1553 (NCT06028841) has been withdrawn.